The links after "Participants" show which SWOG institutions are eligible to participate in this study.
The orange "Where is This Study Open?" tab at the bottom of the page shows the institutions whose Institutional Review Boards (IRBs) have approved the protocol so that it can be opened at that institution. Clicking on the Institution Name will show the points of contact for information about this study at that institution.
- Phase II Pilot(Closed)
A Prospective Blinded Test of the Ability of the Human Tumor Clonogenic Assay to Predict Response in Patients with Superficial Bladder Cancer to Intravesical Adriamycin or Mitomycin-C
Study Coordinator(s): Robert B. Natale, M.D., R.C. Klugo, M.D., H. Barton Grossman, M.D.